Advertisement
Home Tags Clots

Tag: Clots

Introduction of a guideline-based protocol significantly increases compliance with guidelines for prevention of venous thromboembolism

Guideline-Based Protocol Ups Adherence to VTE Prophylaxis

0
Significantly more patients receive VTE prophylaxis after implementation of guideline-based protocol
Completely intracorporeal robotic level III inferior vena cava tumor thrombectomy is feasible

Robotic Sx Feasible for Inferior Vena Cava Thrombectomy

0
Completely intracorporeal robotic level III inferior vena cava tumor thrombectomy viable
Pharmacological thromboprophylaxis does not reduce the risk of venous thromboembolism in patients with cirrhosis

Pharmacological Prophylaxis Doesn’t Cut VTE in Cirrhosis

0
Low rate of VTE in hospitalized patients with cirrhosis; unaffected by pharmacological prophylaxis
Testosterone therapy doesn't appear to increase the risk of venous thromboembolism

No Link Found Between Testosterone Therapy and VTE

0
Finding based on data from more than 30,000 American men, 40 and older
For men with prostate cancer

Prostate Cancer Interacts With Comorbidity to Increase VTE Rate

0
Increased VTE risk among older patients, those with metastases, those who underwent surgery
About 15 percent of patients with post-catheterization femoral pseudoaneurysm who undergo sonographic-guided percutaneous thrombin injection have complications

Channel Length Key in Percutaneous Thrombin Injection

0
Complications for ~15 percent of patients with post-catheterization femoral pseudoaneurysm
Among hospitalized patients

High Doses of Antibiotic Ups Risk of Over-Anticoagulation

0
High-dose amoxicillin/clavulanate combined with warfarin linked to increased risk of INR ≥4
The benefit of extended anticoagulation after pulmonary embolism dissipates after cessation of active therapy

Benefits of Extended Anticoagulation May Not Last

0
New study suggests that oral anticoagulant meds may be needed for the very long term
Kengreal (cangrelor) has been approved by the U.S. Food and Drug Administration to prevent blood clots from forming during angioplasty.

FDA Approves New Antiplatelet Drug for Patients Undergoing PCI

0
Kengreal prevents blood platelets from accumulating during percutaneous coronary intervention
An antibody fragment

Idarucizumab Deemed Effective for Dabigatran Reversal

0
Findings among patients with serious bleeding or who require an urgent procedure